227 related articles for article (PubMed ID: 26232424)
1. USP44+ Cancer Stem Cell Subclones Contribute to Breast Cancer Aggressiveness by Promoting Vasculogenic Mimicry.
Liu T; Sun B; Zhao X; Li Y; Zhao X; Liu Y; Yao Z; Gu Q; Dong X; Shao B; Lin X; Liu F; An J
Mol Cancer Ther; 2015 Sep; 14(9):2121-31. PubMed ID: 26232424
[TBL] [Abstract][Full Text] [Related]
2. Inhibitory effect of melatonin on hypoxia-induced vasculogenic mimicry via suppressing epithelial-mesenchymal transition (EMT) in breast cancer stem cells.
Maroufi NF; Amiri M; Dizaji BF; Vahedian V; Akbarzadeh M; Roshanravan N; Haiaty S; Nouri M; Rashidi MR
Eur J Pharmacol; 2020 Aug; 881():173282. PubMed ID: 32580038
[TBL] [Abstract][Full Text] [Related]
3. Clinical significances and prognostic value of cancer stem-like cells markers and vasculogenic mimicry in renal cell carcinoma.
Zhang Y; Sun B; Zhao X; Liu Z; Wang X; Yao X; Dong X; Chi J
J Surg Oncol; 2013 Nov; 108(6):414-9. PubMed ID: 23996537
[TBL] [Abstract][Full Text] [Related]
4. Phosphorylation of EphA2 receptor and vasculogenic mimicry is an indicator of poor prognosis in invasive carcinoma of the breast.
Mitra D; Bhattacharyya S; Alam N; Sen S; Mitra S; Mandal S; Vignesh S; Majumder B; Murmu N
Breast Cancer Res Treat; 2020 Jan; 179(2):359-370. PubMed ID: 31686261
[TBL] [Abstract][Full Text] [Related]
5. HIF-2α promotes the formation of vasculogenic mimicry in pancreatic cancer by regulating the binding of Twist1 to the VE-cadherin promoter.
Yang J; Zhu DM; Zhou XG; Yin N; Zhang Y; Zhang ZX; Li DC; Zhou J
Oncotarget; 2017 Jul; 8(29):47801-47815. PubMed ID: 28599281
[TBL] [Abstract][Full Text] [Related]
6. Role of X‑linked inhibitor of apoptosis‑associated factor‑1 in vasculogenic mimicry in ovarian cancer.
Wang Y; Liu P; Wang X; Mao H
Mol Med Rep; 2017 Jul; 16(1):325-330. PubMed ID: 28534973
[TBL] [Abstract][Full Text] [Related]
7. OCT4 expression and vasculogenic mimicry formation positively correlate with poor prognosis in human breast cancer.
Liu T; Sun B; Zhao X; Li Y; Gu Q; Dong X; Liu F
Int J Mol Sci; 2014 Oct; 15(11):19634-49. PubMed ID: 25353179
[TBL] [Abstract][Full Text] [Related]
8. Epithelial Mesenchymal Transition and Vascular Mimicry in Breast Cancer Stem Cells.
Kotiyal S; Bhattacharya S
Crit Rev Eukaryot Gene Expr; 2015; 25(3):269-80. PubMed ID: 26558950
[TBL] [Abstract][Full Text] [Related]
9. Effect of Apatinib plus melatonin on vasculogenic mimicry formation by cancer stem cells from breast cancer cell line.
Maroufi NF; Rashidi M; Vahedian V; Jahanbazi R; Mostafaei S; Akbarzadeh M; Kazemzadeh H; Nejabati HR; Isazadeh A; Rashidi MR; Nouri M
Breast Cancer; 2022 Mar; 29(2):260-273. PubMed ID: 34725795
[TBL] [Abstract][Full Text] [Related]
10. Epithelial-to-endothelial transition and cancer stem cells: two cornerstones of vasculogenic mimicry in malignant tumors.
Sun B; Zhang D; Zhao N; Zhao X
Oncotarget; 2017 May; 8(18):30502-30510. PubMed ID: 27034014
[TBL] [Abstract][Full Text] [Related]
11. M2-like tumor-associated macrophages drive vasculogenic mimicry through amplification of IL-6 expression in glioma cells.
Zhang L; Xu Y; Sun J; Chen W; Zhao L; Ma C; Wang Q; Sun J; Huang B; Zhang Y; Li X; Qu X
Oncotarget; 2017 Jan; 8(1):819-832. PubMed ID: 27903982
[TBL] [Abstract][Full Text] [Related]
12. Metalloprotease-disintegrin ADAM12 actively promotes the stem cell-like phenotype in claudin-low breast cancer.
Duhachek-Muggy S; Qi Y; Wise R; Alyahya L; Li H; Hodge J; Zolkiewska A
Mol Cancer; 2017 Feb; 16(1):32. PubMed ID: 28148288
[TBL] [Abstract][Full Text] [Related]
13. Cancer stem-like cells directly participate in vasculogenic mimicry channels in triple-negative breast cancer.
Sun H; Yao N; Cheng S; Li L; Liu S; Yang Z; Shang G; Zhang D; Yao Z
Cancer Biol Med; 2019 May; 16(2):299-311. PubMed ID: 31516750
[TBL] [Abstract][Full Text] [Related]
14. TRIM28 multi-domain protein regulates cancer stem cell population in breast tumor development.
Czerwińska P; Shah PK; Tomczak K; Klimczak M; Mazurek S; Sozańska B; Biecek P; Korski K; Filas V; Mackiewicz A; Andersen JN; Wiznerowicz M
Oncotarget; 2017 Jan; 8(1):863-882. PubMed ID: 27845900
[TBL] [Abstract][Full Text] [Related]
15. Vasculogenic mimicry is associated with trastuzumab resistance of HER2-positive breast cancer.
Hori A; Shimoda M; Naoi Y; Kagara N; Tanei T; Miyake T; Shimazu K; Kim SJ; Noguchi S
Breast Cancer Res; 2019 Aug; 21(1):88. PubMed ID: 31387614
[TBL] [Abstract][Full Text] [Related]
16. CD133+ cells with cancer stem cell characteristics associates with vasculogenic mimicry in triple-negative breast cancer.
Liu TJ; Sun BC; Zhao XL; Zhao XM; Sun T; Gu Q; Yao Z; Dong XY; Zhao N; Liu N
Oncogene; 2013 Jan; 32(5):544-53. PubMed ID: 22469978
[TBL] [Abstract][Full Text] [Related]
17. Slug promoted vasculogenic mimicry in hepatocellular carcinoma.
Sun D; Sun B; Liu T; Zhao X; Che N; Gu Q; Dong X; Yao Z; Li R; Li J; Chi J; Sun R
J Cell Mol Med; 2013 Aug; 17(8):1038-47. PubMed ID: 23815612
[TBL] [Abstract][Full Text] [Related]
18. CD44 enhances tumor aggressiveness by promoting tumor cell plasticity.
Paulis YW; Huijbers EJ; van der Schaft DW; Soetekouw PM; Pauwels P; Tjan-Heijnen VC; Griffioen AW
Oncotarget; 2015 Aug; 6(23):19634-46. PubMed ID: 26189059
[TBL] [Abstract][Full Text] [Related]
19. ALDH1 Expression and Vasculogenic Mimicry Are Positively Associated with Poor Prognosis in Patients with Breast Cancer.
Xing P; Dong H; Liu Q; Zhao T; Yao F; Xu Y; Chen B; Zheng X; Wu Y; Jin F; Li J
Cell Physiol Biochem; 2018; 49(3):961-970. PubMed ID: 30184527
[TBL] [Abstract][Full Text] [Related]
20. Function of AURKA protein kinase in the formation of vasculogenic mimicry in triple-negative breast cancer stem cells.
Liu Y; Sun B; Liu T; Zhao X; Wang X; Li Y; Meng J; Gu Q; Liu F; Dong X; Liu P; Sun R; Zhao N
Onco Targets Ther; 2016; 9():3473-84. PubMed ID: 27366084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
